Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Jennifer Evans Stacey currently holds 45,000 shares of AUXILIUM PHARMACEUTICALS INC (AUXL), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Jennifer Evans Stacey has been a net seller of AUXL stock. They have purchased $0 and sold $745.1K worth of shares.
Jennifer Evans Stacey's most recent insider trade was on Jun 24, 2026, when they sold 45,000 shares at $0.00 per share.
Jennifer Evans Stacey serves as Executive at AUXILIUM PHARMACEUTICALS INC (AUXL). They have executed 27 insider transactions totaling $745.1K over their tenure at the company.
Jennifer Evans Stacey holds the position of Executive at AUXILIUM PHARMACEUTICALS INC, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 18 years and currently hold a stake valued at $0.
Jennifer Evans Stacey has shown a selling trading pattern, with $0 in total purchases and $745.1K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Jennifer Evans Stacey was on May 1, 2026, when they purchased $375.0K worth of NEOG shares. This transaction involved 39,349 shares at $9.53 per share.
Jennifer Evans Stacey currently owns 45,000 shares of AUXILIUM PHARMACEUTICALS INC (AUXL), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Jennifer Evans Stacey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Jennifer Evans Stacey has 27 Form 4 filings on record as an insider at AUXILIUM PHARMACEUTICALS INC.
Set alerts for Jennifer Evans Stacey and 40,000+ other insiders.